BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 32799336)

  • 1. First-trimester absent nasal bone: is it a predictive factor for pathogenic CNVs in the low-risk population?
    Fantasia I; Stampalija T; Sirchia F; Della Pietà I; Ottaviani Giammarco C; Guidolin F; Quadrifoglio M; Barresi V; Travan L; Faletra F
    Prenat Diagn; 2020 Dec; 40(12):1563-1568. PubMed ID: 32799336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selection of prenatal screening with nuchal translucency > 95th centile and below 99th centile: a 4-year observational study with real-world data.
    Zhang B; Zhang LX; Yi J; Wang CH; Zhao Y
    Arch Gynecol Obstet; 2024 Apr; ():. PubMed ID: 38625542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Analysis of copy number variation by CMA in fetus with increased nuchal translucency].
    Du L; Xie HN; Zheng J; He M
    Zhonghua Fu Chan Ke Za Zhi; 2018 Oct; 53(10):671-676. PubMed ID: 30369122
    [No Abstract]   [Full Text] [Related]  

  • 4. Absence of fetal nasal bone and aneuploidies at first-trimester nuchal translucency screening in unselected pregnancies.
    Zoppi MA; Ibba RM; Axiana C; Floris M; Manca F; Monni G
    Prenat Diagn; 2003 Jun; 23(6):496-500. PubMed ID: 12813765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical application of chromosomal microarray analysis in fetuses with increased nuchal translucency and normal karyotype.
    Su L; Huang H; An G; Cai M; Wu X; Li Y; Xie X; Lin Y; Wang M; Xu L
    Mol Genet Genomic Med; 2019 Aug; 7(8):e811. PubMed ID: 31209990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Should cell-free DNA testing be used in pregnancy with increased fetal nuchal translucency?
    Miranda J; Paz Y Miño F; Borobio V; Badenas C; Rodriguez-Revenga L; Pauta M; Borrell A
    Ultrasound Obstet Gynecol; 2020 May; 55(5):645-651. PubMed ID: 31301176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessing the value of second-trimester nasal bone hypoplasia in predicting chromosomal abnormalities: a retrospective chromosomal microarray analysis of 351 fetuses.
    Pan L; Liang H; Meng Z; Wang J; Zhang R; Wu Y
    Arch Gynecol Obstet; 2023 Oct; 308(4):1263-1270. PubMed ID: 36269386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prenatal diagnosis of fetuses with absent/hypoplastic nasal bone in second-trimester using chromosomal microarray analysis.
    Chen X; Jiang Y; Zeng S; Zhuang J; Lin N
    Birth Defects Res; 2024 May; 116(5):e2351. PubMed ID: 38766695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. First-trimester screening for chromosomal abnormalities by integrated application of nuchal translucency, nasal bone, tricuspid regurgitation and ductus venosus flow combined with maternal serum free β-hCG and PAPP-A: a 5-year prospective study.
    Ghaffari SR; Tahmasebpour AR; Jamal A; Hantoushzadeh S; Eslamian L; Marsoosi V; Fattahi F; Rajaei M; Niroomanesh S; Borna S; Beigi A; Khazardoost S; Saleh-Gargari S; Rahimi-Sharbaf F; Farrokhi B; Bayani N; Tehrani SE; Shahsavan K; Farzan S; Moossavi S; Ramezanzadeh F; Dastan J; Rafati M
    Ultrasound Obstet Gynecol; 2012 May; 39(5):528-34. PubMed ID: 21793085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prospective cohort study of fetal nuchal translucency in first-trimester and pregnancy outcome].
    Tang HR; Zhang Y; Ru T; Li J; Yang L; Xu Y; Duan HL; Wang Y; Wang Y; Hu YL; Zhang Y; Zheng MM
    Zhonghua Fu Chan Ke Za Zhi; 2020 Feb; 55(2):94-99. PubMed ID: 32146737
    [No Abstract]   [Full Text] [Related]  

  • 11. Application of chromosomal microarray in fetuses with increased nuchal translucency.
    Zhao XR; Gao L; Wu Y; Wang YL
    J Matern Fetal Neonatal Med; 2020 May; 33(10):1749-1754. PubMed ID: 30688128
    [No Abstract]   [Full Text] [Related]  

  • 12. Likelihood ratio for trisomy 21 in fetuses with absent nasal bone at the 11-14-week scan.
    Cicero S; Rembouskos G; Vandecruys H; Hogg M; Nicolaides KH
    Ultrasound Obstet Gynecol; 2004 Mar; 23(3):218-23. PubMed ID: 15027007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Whole exome sequencing in fetuses with isolated increased nuchal translucency: a systematic review and meta-analysis.
    Di Girolamo R; Rizzo G; Khalil A; Alameddine S; Lisi G; Liberati M; Novelli A; D'Antonio F
    J Matern Fetal Neonatal Med; 2023 Dec; 36(1):2193285. PubMed ID: 37019452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nuchal translucency and nasal bone for trisomy 21 screening: single center experience.
    Monni G; Zoppi MA; Ibba RM; Floris M; Manca F; Axiana C
    Croat Med J; 2005 Oct; 46(5):786-91. PubMed ID: 16158472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The clinical impact of the first-trimester nuchal translucency between the 95th-99th percentiles.
    Fantasia I; Catagini S; Zamagni G; Greco P; Bianchini I; Bussolaro S; Quadrifoglio M; Lo Bello L; Monasta L; Ricci G; Faletra F; Feresin A; Stampalija T
    Prenat Diagn; 2023 Jun; 43(7):929-936. PubMed ID: 37264704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased nuchal translucency thickness and normal karyotype: time for parental reassurance.
    Bilardo CM; Müller MA; Pajkrt E; Clur SA; van Zalen MM; Bijlsma EK
    Ultrasound Obstet Gynecol; 2007 Jul; 30(1):11-8. PubMed ID: 17559183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. First-trimester screening for trisomies 18 and 13, triploidy and Turner syndrome by detailed early anomaly scan.
    Wagner P; Sonek J; Hoopmann M; Abele H; Kagan KO
    Ultrasound Obstet Gynecol; 2016 Oct; 48(4):446-451. PubMed ID: 26611869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. First-trimester assessment of nasal bone using retronasal triangle view: a prospective study.
    Adiego B; Martinez-Ten P; Illescas T; Bermejo C; Sepulveda W
    Ultrasound Obstet Gynecol; 2014 Mar; 43(3):272-6. PubMed ID: 23733531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between nuchal translucency thickness and prevalence of major cardiac defects in fetuses with normal karyotype.
    Atzei A; Gajewska K; Huggon IC; Allan L; Nicolaides KH
    Ultrasound Obstet Gynecol; 2005 Aug; 26(2):154-7. PubMed ID: 15977311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Study on several ultrasound markers combined maternal serum biochemical markers to screen fetal chromosomal aneuploidy at 11 to 13(+)6 weeks of gestation].
    Chen X; Chang Y; Cui HY; Ren CC; Yu BY
    Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):815-8. PubMed ID: 24444556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.